Chemocentryx Inc. is a biopharmaceutical company focused on discovering developing and commercializing orally-administered therapeutics to treat autoimmune diseases inflammatory disorders and cancer.


Updates from The Motley Fool

Latest updates on ChemoCentryx from Fool.com.


Stock Performance

CCXI vs. S&P 500 | 2 Year Performance
View Interactive CCXI Charts
Sponsored by

Key Data Points

Primary metrics and data points about ChemoCentryx.
Current Price: $4.63
Prev Close: $4.68
Open: $4.66
Bid: $4.10
Ask: $5.00
Day's Range: $4.57 - $4.70
52wk Range: $1.92 - $8.84
Volume: 60,056
Avg Vol 348,515
Market Cap: $204.33M
P/E (ttm): 4.59
EPS (ttm): $1.02
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ChemoCentryx.
CAPS Rating 3 out of 5
 
52 Outperform
5 Underperform
CAPS All Stars
 
13 Outperform
3 Underperform

How do you think ChemoCentryx will perform against the market?



You pick for ChemoCentryx is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Thomas J. Schall, CEO

0% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ChemoCentryx.

Chemocentryx Inc. is a biopharmaceutical company focused on discovering developing and commercializing orally-administered therapeutics to treat autoimmune diseases inflammatory disorders and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers